B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

TARDBP

MOLECULAR TARGET

TAR DNA binding protein

UniProt: Q13148NCBI Gene: 2343519 compounds

TARDBP (TAR DNA binding protein) is targeted by 19 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting TARDBP

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Dehydroepiandrosterone0.691
2Progesterone0.691
3pterostilbene0.691
4sesamin0.691
5Simvastatin0.691
6Androsterone0.691
7Chenodeoxycholic Acid0.691
8Chlorhexidine0.691
9Dehydroepiandrosterone0.691
10Dideoxyadenosine0.691
11Dinitrochlorobenzene0.691
12Equilin0.691
13Estrone0.691
14mg6240.691
15Nisoldipine0.691
16Nitrendipine0.691
17paxilline0.691
18Riluzole0.691
19Testosterone Propionate0.691

About TARDBP as a Drug Target

TARDBP (TAR DNA binding protein) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 19 compounds with documented TARDBP interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

TARDBP inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.